Pharmacognosy Magazine

ORIGINAL ARTICLE
Year
: 2015  |  Volume : 11  |  Issue : 42  |  Page : 250--256

Shikonin induces apoptosis in the human gastric cancer cells HGC-27 through mitochondria-mediated pathway


Yue Hou1, Jinghua Xu2, Xia Liu3, Xichun Xia4, Ning Li5, Xiuli Bi4 
1 Department of Biochemistry and Molecular Biology, College of Life and Health Sciences, Northeastern University, Shenyang 110004, China
2 Department of Pharmacology, School of Life Science and Biopharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang 110016, China
3 Department of Biochemistry and Molecular Biology, College of Life and Health Sciences, Northeastern University, Shenyang 110004; Department of Pharmacology, School of Life Science and Biopharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang 110016, China
4 Department of Biochemistry and Molecular Biology, School of Life Science, Liaoning University, Shenyang, 110036, China
5 Department of Natural Product Chemistry, School of Traditional Chinese Materia Medica, Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China

Correspondence Address:
Xiuli Bi
School of Life science, Liaoning University, Shenyang 110036
China
Yue Hou
College of Life and Health Sciences, Northeastern University, Shenyang 110004
China

Background: Gastric cancer (GC) is one of the most frequently occurring digestive tract cancers and fewer chemotherapeutic drugs for GC have shown promising results. In this study, we investigated the anti-tumor activity of shikonin, a natural compound isolated from the Chinese plant Lithospermum erythrorhizon, against the human GC cell line HGC-27. Materials and Methods: HGC-27 cells treated with shikonin at a concentration of 30μM or above showed significant growth inhibition compared to control cells. Shikonin-treated cells also underwent apoptosis as detected by flow cytometric analysis and microscopic examination of cellular morphology. Further investigation into the underlying mechanism of apoptosis by western blot showed that the shikonin promoted the activation of poly-(ADP-ribose)-polymerase, caspase-3 and caspase-9 following 24 h or 48 h of treatment time, as well as the activation of caspase-8, but only after 48 h of treatment time. Furthermore, the levels of mitochondrial membrane potential, B-cell lymphoma 2 (Bcl-2) and Bcl-extra large were reduced following shikonin treatment while the level of Bax was increased. In addition, shikonin also caused a signifi cant reduction of the protein Survivin, while having little effect on the expression on X-linked inhibitor of apoptosis protein. Conclusion: Taken together, these results showed that the shikonin exhibited its anti-tumor activity against HGC-27 cells through inhibiting cell growth and promoting apoptosis by targeting mitochondrial-related signaling pathway. Our finding may represent a positive step in finding a natural and effective compound that could be important implication for future development of chemotherapeutic and/or chemopreventive agent against GC.


How to cite this article:
Hou Y, Xu J, Liu X, Xia X, Li N, Bi X. Shikonin induces apoptosis in the human gastric cancer cells HGC-27 through mitochondria-mediated pathway.Phcog Mag 2015;11:250-256


How to cite this URL:
Hou Y, Xu J, Liu X, Xia X, Li N, Bi X. Shikonin induces apoptosis in the human gastric cancer cells HGC-27 through mitochondria-mediated pathway. Phcog Mag [serial online] 2015 [cited 2019 Oct 16 ];11:250-256
Available from: http://www.phcog.com/article.asp?issn=0973-1296;year=2015;volume=11;issue=42;spage=250;epage=256;aulast=Hou;type=0